RNTX vs SOFI · $80.6M cap vs P/E 39, rev $283.1M
Rein Therapeutics Inc (RNTX) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ. It is led by Anthony J. Noto.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
RNTX currently screens at market cap $80.6M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the RNTX and SOFI stock pages for the full models.
Not investment advice.